Transaction in Own Shares

Summary by AI ^BETAClose X

Melrose Industries PLC has purchased a total of 340,386 ordinary shares between April 20th and April 24th, 2026, through Merrill Lynch International. The volume-weighted average purchase price ranged from 502.64p to 554.60p, with individual share prices varying between 495.10p and 559.80p. These acquired shares will be held in treasury, bringing the total number of shares held in treasury to 63,687,214, with 1,247,788,107 ordinary shares remaining in issue.

Disclaimer*

Melrose Industries PLC

27 April 2026


27ᵗʰ April 2026
Melrose Industries PLC
("Melrose" or the "Company")
Transaction in Own Shares

The Company announces today it has purchased the following number of its ordinary shares of £0.001 each through Merrill Lynch International ("MLI") in the period from 20ᵗʰ April 2026 to 24ᵗʰ April 2026.

Date	Venue	Volume-weighted average price (p)	Aggregated volume	Lowest price per share (pence)	Highest price per share (p)
20 April 2026	XLON	554.6023	56,000	546.8000	557.4000
21 April 2026	XLON	542.5244	57,000	532.4000	559.8000
22 April 2026	XLON	505.5580	60,000	498.1000	522.2000
23 April 2026	XLON	504.6779	64,386	495.7000	512.8000
24 April 2026	XLON	502.6364	63,000	495.1000	506.4000


The Company intends to hold the purchased shares in treasury.

Following the above transaction, the Company has 63,687,214 ordinary shares in treasury and has 1,247,788,107 ordinary shares in issue (excluding treasury shares).


Individual Transactions
In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014 as it forms part of UK law, a full breakdown of the individual trades made by the MLI on behalf of the Company as part of the buyback programme is attached to this announcement.
http://www.rns-pdf.londonstockexchange.com/rns/9965B_1-2026-4-26.pdf

For further information please contact:
Warren Fernandez Company Secretary

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END